Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Renée D. Galá
CEORenée D. Galá
Employees
2,890
Employees2,890
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,890
Employees2,890

JAZZ Key Statistics

Market cap
14.17B
Market cap14.17B
Price-Earnings ratio
-12,271.20
Price-Earnings ratio-12,271.20
Dividend yield
Dividend yield
Average volume
979.61K
Average volume979.61K
High today
$230.00
High today$230.00
Low today
$223.34
Low today$223.34
Open price
$228.55
Open price$228.55
Volume
741.24K
Volume741.24K
52 Week high
$230.40
52 Week high$230.40
52 Week low
$97.56
52 Week low$97.56

Stock Snapshot

With a market cap of 14.17B, Jazz Pharmaceuticals(JAZZ) trades at $225.79. The stock has a price-to-earnings ratio of -12271.20.

On 2026-05-09, Jazz Pharmaceuticals(JAZZ) stock moved within a range of $223.34 to $230.00. With shares now at $225.79, the stock is trading +1.1% above its intraday low and -1.8% below the session's peak.

Trading volume for Jazz Pharmaceuticals(JAZZ) stock has reached 741.24K, versus its average volume of 979.61K.

The stock's 52-week range extends from a low of $97.56 to a high of $230.40.

The stock's 52-week range extends from a low of $97.56 to a high of $230.40.

JAZZ News

TipRanks 2d
Jazz Pharmaceuticals Signals Confidence After Record Quarter

Jazz Pharmaceuticals ((JAZZ)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data an...

The Motley Fool 3d
Jazz Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. May 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Renée Galá Chief Commercial Officer — Sama...

Jazz Q1 2026 Earnings Call Transcript
TipRanks 4d
Jazz Pharmaceuticals reports Q1 adjusted EPS $6.34, consensus $4.66

GAAP EPS was $4.43. Reports Q1 revenue $1.07B, consensus $979.01M. “Our first-quarter results reflect disciplined execution across the business, delivering 19%...

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.